TAVR vs SAVR long-term mortality due to stroke and MI: A meta-analysis during COVID 19 pandemic

Abstract

Review question / Objective: If TAVR is a viable treatment option to prevent early stroke mortality in patients of low and intermediate risk compared to SAVR? It is not viable in the long-term at 5 or over years? Condition being studied: Transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), stroke, MI. METHODS Search strategy: An electronic search of MEDLINE, Google Scholar, and Cochrane INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols INPLASY PROTOCOL TAVR vs SAVR long-term mortality due to stroke and MI: A meta-analysis during COVID 19 pandemic Serbanoiu, LI 1 ; Ion, AC 2 ; Plesu, E 3 ; Busnatu, SS 4 ; Andrei, CL 5 . To cite: Serbanoiu et al. TAVR vs SAVR long-term mortality due to stroke and MI: A metaanalysis during COVID 19 pandemic. Inplasy protocol 2022110110.